Record Details

Valuation of Biotechnological Research: A Real Options Application for a Mexican Company

Kasarinlan: Philippine Journal of Third World Studies

View Archive Info
 
 
Field Value
 
Title Valuation of Biotechnological Research: A Real Options Application for a Mexican Company
 
Creator Martinez-Miranda, Elio
Cabello Rosales, Alejandra
Ortiz, Edgar
 
Subject Finance
Real Options; valuation biothec; compound options; antivenoms; Mexico
Valuation of Biotechnological Research
 
Description This paper deals with the valuation of a project of Mexican Bioclon Institute, a firm producing antivenoms; this valuation comprises a R&D research portfolio of three antivenoms targeted to the US market. A compound option methodology is used. Bioclon Institute is a world leader in the production, research and development of fabotherapics; these products are manufactured using its own technology, recognized internationally; it is a large company of antivenoms globally and it is the only Mexican biotech company authorized by the US to conduct clinical trials. Real Options valuation constitutes an important analytical tool of limited use by managers and entrepreneurs in developing countries because they are not fully aware about this methodology and its benefits for strategic sequential project analysis. 
 
Publisher Scitech Research Organisation
 
Contributor —
 
Date 2018-02-10
 
Type info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
Peer-reviewed Article
Real options
 
Format application/pdf
 
Identifier http://www.scitecresearch.com/journals/index.php/jrbem/article/view/1400
 
Source Journal of Research in Business, Economics and Management; Vol 10, No 2: JRBEM; 1824-1843
 
Language eng
 
Relation http://www.scitecresearch.com/journals/index.php/jrbem/article/view/1400/998
 
Coverage Mexico
—
—
 
Rights Copyright (c) 2018 Journal of Research in Business, Economics and Management